Outcomes of older patients in ZUMA-1, a pivotal study of axicabtagene ciloleucel in refractory large B-cell lymphoma

Sattva S. Neelapu; Caron A. Jacobson; Olalekan O. Oluwole; Javier Munoz; Abhinav Deol; David B. Miklos; Nancy L. Bartlett; Ira Braunschweig; Yizhou Jiang; Jenny J. Kim; Lianqing Zheng; John M. Rossi; Frederick L. Locke

doi:10.1182/BLOOD.2019004162

Outcomes of older patients in ZUMA-1, a pivotal study of axicabtagene ciloleucel in refractory large B-cell lymphoma

Sattva S. Neelapu
, Caron A. Jacobson
, Olalekan O. Oluwole
, Javier Munoz
, Abhinav Deol
, David B. Miklos
, Nancy L. Bartlett
, Ira Braunschweig
, Yizhou Jiang
, Jenny J. Kim
, Lianqing Zheng
, John M. Rossi
, Frederick L. Locke

Medicine

Research output: Contribution to journal › Letter › peer-review

132 Scopus citations

Original language	English (US)
Pages (from-to)	2106-2109
Number of pages	4
Journal	Blood
Volume	135
Issue number	23
DOIs	https://doi.org/10.1182/BLOOD.2019004162
State	Published - Jun 4 2020

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/BLOOD.2019004162

Cite this

Neelapu, S. S., Jacobson, C. A., Oluwole, O. O., Munoz, J., Deol, A., Miklos, D. B., Bartlett, N. L., Braunschweig, I., Jiang, Y., Kim, J. J., Zheng, L., Rossi, J. M., & Locke, F. L. (2020). Outcomes of older patients in ZUMA-1, a pivotal study of axicabtagene ciloleucel in refractory large B-cell lymphoma. Blood, 135(23), 2106-2109. https://doi.org/10.1182/BLOOD.2019004162

@article{303cb197416b436d9750c012c463eb0d,

title = "Outcomes of older patients in ZUMA-1, a pivotal study of axicabtagene ciloleucel in refractory large B-cell lymphoma",

author = "Neelapu, \{Sattva S.\} and Jacobson, \{Caron A.\} and Oluwole, \{Olalekan O.\} and Javier Munoz and Abhinav Deol and Miklos, \{David B.\} and Bartlett, \{Nancy L.\} and Ira Braunschweig and Yizhou Jiang and Kim, \{Jenny J.\} and Lianqing Zheng and Rossi, \{John M.\} and Locke, \{Frederick L.\}",

note = "Funding Information: This work was supported by Kite, a Gilead Company, and the Leukemia and Lymphoma Society Therapy Acceleration Program. Medical writing support was provided by Jennifer Leslie, of Nexus Global Group Science, with funding from Kite.",

year = "2020",

month = jun,

day = "4",

doi = "10.1182/BLOOD.2019004162",

language = "English (US)",

volume = "135",

pages = "2106--2109",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

number = "23",

}

TY - JOUR

T1 - Outcomes of older patients in ZUMA-1, a pivotal study of axicabtagene ciloleucel in refractory large B-cell lymphoma

AU - Neelapu, Sattva S.

AU - Jacobson, Caron A.

AU - Oluwole, Olalekan O.

AU - Munoz, Javier

AU - Deol, Abhinav

AU - Miklos, David B.

AU - Bartlett, Nancy L.

AU - Braunschweig, Ira

AU - Jiang, Yizhou

AU - Kim, Jenny J.

AU - Zheng, Lianqing

AU - Rossi, John M.

AU - Locke, Frederick L.

N1 - Funding Information: This work was supported by Kite, a Gilead Company, and the Leukemia and Lymphoma Society Therapy Acceleration Program. Medical writing support was provided by Jennifer Leslie, of Nexus Global Group Science, with funding from Kite.

PY - 2020/6/4

Y1 - 2020/6/4

UR - https://www.scopus.com/pages/publications/85085664138

UR - https://www.scopus.com/pages/publications/85085664138#tab=citedBy

U2 - 10.1182/BLOOD.2019004162

DO - 10.1182/BLOOD.2019004162

M3 - Letter

C2 - 32181801

AN - SCOPUS:85085664138

SN - 0006-4971

VL - 135

SP - 2106

EP - 2109

JO - Blood

JF - Blood

IS - 23

ER -

Outcomes of older patients in ZUMA-1, a pivotal study of axicabtagene ciloleucel in refractory large B-cell lymphoma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this